The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(3,5-Diiodo-4-methoxy-benzyl)-1,2,3,4-tetrahydro-isoquinoline-6,7-diol ID: ALA308351
PubChem CID: 9871887
Max Phase: Preclinical
Molecular Formula: C17H17I2NO3
Molecular Weight: 537.13
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1c(I)cc(CC2NCCc3cc(O)c(O)cc32)cc1I
Standard InChI: InChI=1S/C17H17I2NO3/c1-23-17-12(18)4-9(5-13(17)19)6-14-11-8-16(22)15(21)7-10(11)2-3-20-14/h4-5,7-8,14,20-22H,2-3,6H2,1H3
Standard InChI Key: CCQIDZRURGYWNQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
5.5542 -5.8125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6292 -7.6125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0375 -6.1125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0792 -6.1125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5542 -5.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1042 -7.9125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6292 -7.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5167 -5.8125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5917 -7.0125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0375 -4.9042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5167 -5.2125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6000 -5.8125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5917 -7.6125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1125 -6.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0750 -6.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1500 -6.7042 0.0000 I 0 0 0 0 0 0 0 0 0 0 0 0
7.1042 -8.5125 0.0000 I 0 0 0 0 0 0 0 0 0 0 0 0
8.1500 -7.9125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0000 -6.1125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6000 -5.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0000 -4.9125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0792 -4.9042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1500 -8.5125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 7 1 0
3 1 2 0
4 1 1 0
5 1 1 0
6 13 1 0
7 14 2 0
8 3 1 0
9 15 1 0
10 5 2 0
11 10 1 0
12 4 1 0
13 9 2 0
14 9 1 0
15 4 1 0
16 7 1 0
17 6 1 0
18 2 1 0
19 8 1 0
20 22 1 0
21 11 1 0
22 5 1 0
23 18 1 0
20 12 1 0
8 11 2 0
2 6 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 537.13Molecular Weight (Monoisotopic): 536.9298AlogP: 3.75#Rotatable Bonds: 3Polar Surface Area: 61.72Molecular Species: NEUTRALHBA: 4HBD: 3#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.52CX Basic pKa: 8.50CX LogP: 4.42CX LogD: 3.50Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.41Np Likeness Score: 1.22
References 1. Zheng W, Nikulin VI, Konkar AA, Vansal SS, Shams G, Feller DR, Miller DD.. (1999) 2-Amino-4-benzyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridines: novel selective beta3-adrenoceptor agonists., 42 (12): [PMID:10377236 ] [10.1021/jm990012z ] 2. De Los Angeles JE, Nikulin VI, Shams G, Konkar AA, Mehta R, Feller DR, Miller DD.. (1996) Iodinated analogs of trimetoquinol as highly potent and selective beta 2-adrenoceptor ligands., 39 (19): [PMID:8809159 ] [10.1021/jm960208o ] 3. He Y, Nikulin VI, Vansal SS, Feller DR, Miller DD.. (2000) Synthesis and human beta-adrenoceptor activity of 1-(3,5-diiodo-4- methoxybenzyl)-1,2,3,4-tetrahydroisoquinolin-6-ol derivatives in vitro., 43 (4): [PMID:10691685 ] [10.1021/jm990463j ] 4. Christoff JJ, Bradley L, Miller DD, Lei L, Rodriguez F, Fraundorfer P, Romstedt K, Shams G, Feller DR.. (1997) Synthesis and evaluation of trimetoquinol derivatives: novel thromboxane A2/prostaglandin H2 antagonists with diminished beta-adrenergic agonist activity., 40 (1): [PMID:9016331 ] [10.1021/jm950896w ]